Cart
sales@molnova.com
Thonningianin A
CAS No. 271579-11-4
Thonningianin A( —— )
Catalog No. M18340 CAS No. 271579-11-4
Thonningianin A has antioxidant property, involves radical scavenging, anti-superoxide formation and metal chelation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 163 | In Stock |
|
| 2MG | 59 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 262 | In Stock |
|
| 50MG | 369 | In Stock |
|
| 100MG | 556 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThonningianin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionThonningianin A has antioxidant property, involves radical scavenging, anti-superoxide formation and metal chelation.
-
DescriptionThonningianin A has anti-cancer activities.Thonningianin A represents a new potent glutathione S-transferase in vitro inhibitor.Thonningianin A has antioxidant property, involves radical scavenging, anti-superoxide formation and metal chelation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number271579-11-4
-
Formula Weight874.71
-
Molecular FormulaC42H34O21
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (114.32 mM)
-
SMILESC1[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C(C(=C3)O)C(=O)CCC4=CC=CC=C4)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6C7=C(C(=C(C=C7C(=O)O1)O)O)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SP-100030
SP-100030 is a dual inhibitor of NF-κB and activator protein-1 (AP-1), demonstrating potent inhibition with IC50 values of 50 nM for both.
-
AM-0216
AM-0216 (AM0216) is a highly potent inhibitor of NF-κB inducing Kinase (NIK).
-
GGTI 2147
GGTI 2147 decreased Rac1 activity, down-regulated p65 expression, and ameliorated OGD/R-induced neuronal apoptosis.
